Peer Review History
Original SubmissionFebruary 4, 2021 |
---|
PONE-D-21-03875 Determinants of obstructed labor and its adverse outcomes among women who gave birth in Hawassa University Referral Hospital: A case control study PLOS ONE Dear Dr. Desta, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please respond to the reviewers' thoughtful comments. In particular, please include a description of all the determinants of obstructed labour reported previously in other studies in the background section; elaborate on the sample size; and rewrite the Discussion section. Please correct grammatical and spelling errors. Please submit your revised manuscript by Nov 25 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Nancy Beam, PhD Staff Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for including your ethics statement: "The study protocol was reviewed and approved by Hawassa University, College of Medicine and Health Science Institutional Review Board (IRB) committee with a Ref. No IRB/163/10. Official letter of cooperation was obtained from College of Medicine and Health Science to Hawassa specialized Hospital and permission was secured from medical director. The consent was ***consent was waived by an IRB ***. All study participants charts were reviewed and returned after data extraction. Information obtained in the study was stored confidentially. ". Please amend your current ethics statement to include the full name of the ethics committee that approved your specific study / waived the need of consent.. Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”). For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research. 3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. 5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Good study on determiants of OL and its outcomes in Hawassa University Referral Hospital. Abastract: In the methods area mention should be made of the fact that the study was based on patient records/charts. Background: Authors ought to refer to a similar study conducted by Mulugeta et al. 2020. Reasons as to why the study was done in Hawassa? Results: Well presented though the tables appear vebe very long. Discussion: Please authors include freference to a study by Mululeta Dile et al. (2020) titled: Determinants of obstructed labour among women attending intrapartum care in Amhara Region NW Ethiopia: a hospital based unmatched case-control study. In the the limitations there is no mention about missing data which is common iin use of secondary data. Conclusion: Strong recommendation on the use of family planning though relevant but does not come directly from the data. General comment: authors should try and correct the spelling and grammatical errors. Reviewer #2: 1. Generally, the article is very important to share with the wider community as it addresses determinants of obstructed labour which is one of the direct causes of maternal deaths. Knowing the determinants of obstructed labour will help to put measures that will improve maternal health and ultimately reduce maternal mortality. 2. The abstract is more than 300 words based on journal guidelines, try to reduce redundant words. 3. There were a lot of grammatical errors throughout the documents. Needs to revise the whole document. 4. Background: The authors need to unpack and describe all the determinants of obstructed labour reported previously in other studies in the background section,. 5. Ethic: In Ethics statement line 4, correct repeated word, “consent was” 6. Sample size: The sample size calculation is not well computed; This is a case control study and decided to take a ratio of 1:2, how did you arrive with a total number of 486 women (162 women for cases and 324 women for controls)?. This should be well elaborated 7. Methods: In the Method section, under “Study design, setting and population” line 14..This sentence is not clear, “All women who gave birth after 28 weeks of gestation or weight of at least 1000 gm were included in the study” 8. Discussion: In this section: For the reader to follow, it is best to give the summary of key important findings in the first paragraph, and in the subsequent paragraphs to continue discussing your findings by comparing with other previously reported studies. It is also important to minimize repeating describing your findings in the discussion section. The discussion of your findings should be explicitly discussed since then all your results have been well elaborated in your results section. Eg. “The absence of partograph utilization observed in this study as one of the major determinant factors of OL was also reported in other studies in Ethiopia”. In addition, avoid reporting the odds ratio, percentages ( %), CI, P-Values in the discussion part. Just report in wording the interpretation of your findings and compare them with other previous studies. Prefer to speak, half of.., a third of.. rather than 50.3%, etc. 9. Some abbreviations have not been fully expressed at first use like “NICU” 10. Conclusion support the data presented in the study 11. For Table 3: (Determinants of obstructed labour in Hawassa Referral Hospital, Ethiopia); since it is long, no need for the subheading, just leave it for it to continue as it is. 12. Maintain continuity of the layout of all tables as instructed by the journal, Table 4 has a different layout compared with other tables. 13. It is advisable to follow the journal guidelines: For the PLOS one, the manuscript should be double spaced, with line numbers etc… 14. Revise your reference list to be consistent, eg. Number 50. The authors' list has small capitals. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
PONE-D-21-03875R1 Determinants of obstructed labour and its adverse outcomes among women who gave birth in Hawassa University Referral Hospital: A case-control study PLOS ONE Dear Dr. Melaku Desta, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 05 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Veneranda Masatu Bwana, MD, MSc, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments (if provided): 1. Congrats to the authors for improving the manuscript. However, some of the comments from the reviews have not been satisfied. 2. The abstract is still more than 300 words. The abstract has a number of irrelevant words which could be omitted. Eg, in the Methods paragraph, words like… “ odds ratio/CI/ Statistical significance was declared when the p-value was less than 0.05” are not necessary to mention here. I will advise the authors to revisit the abstract again to be clear, short, and precise to comply with the journal requirements. 3. Some grammatical errors and tenses have not yet been satisfied, eg. “…sample size is …” instead of “…sample size was….”. Revise the whole document to clear all the minor spelling and tenses. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
Revision 2 |
Determinants of obstructed labour and its adverse outcomes among women who gave birth in Hawassa University Referral Hospital: A case-control study PONE-D-21-03875R2 Dear Dr. Desta, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Veneranda Masatu Bwana, MD, MSc, PhD Guest Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #3: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #3: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #3: Title: Determinants of obstructed labour and its adverse outcomes among women who gave birth in Hawassa University Referral Hospital: A case-control study � It is an interesting topic in developing countries. Abstract: � Is ok. Except for the recommendation part that needs revision. Background: � The last statement of the 1st paragraph … obstructed cases, must be corrected as Obstetric causes. � Second paragraph.. In Ethiopia, OL is associated with 3% of maternal death, 37.5% to 70% of perinatal deaths [9], and 36% of maternal death in Ethiopia. Why is this variation in the contribution of OL to maternal death? Which one is more likely true to cite? � The background is better rewritten as first the global perspective, then regional and national. In this case, it is not organized in this way. More recent literature on the title has to be included. Method: � The study population is stated as… “Randomly selected women who gave birth in the last 3 years and fulfilled the inclusion criteria were the study population” how many OL was in the past three years to randomly collect the study population from? � How were the cases and controls identified? This must have been described in the data collection procedure part. � The criteria put under the definition of OL and clinical pelvimetry are not correct and confusing, and it has to follow only the standard definition that is put under the introduction. � Why were preterm included? It is less likely to have obstructed labor in preterm. Result: � Why 156 out of 162? The reason has to be explained. Was the information incomplete or what? � Terms like more than half, two-third, etc, have to be avoided and the exact figure has to be described � The finding..More than one-fourth (28.2%) of cases had contracted pelvis.. is an unusual finding. It is overinflated. � The classification of gestational age in table 2 to <42 wks and > or =42 wks is not appropriate. Further classification is needed. You may consider <37 wks, 37 to 42 wks, and >42 wks. Similarly, you have to choose one classification for birth weight. The latter is appropriate (Table3). Do all the women know their gestational age or LNMP? You didn’t use another surrogate to estimate gestational age. � What would be the explanation for the finding…. Primiparous women were 81% times [AOR= 0.19, 95% CI: 0.07, 0.52] and multigravida women were 83% times [AOR = 0.17, 95 % CI: 0.07, 0.41] less likely to have OL than grand multiparous women. Is primigravida not at risk of having OL than multigravida? � Another query..Similarly, women who had contracted pelvis were about 4 times more likely to have the chance of obstructed labour than those who had adequate pelvis [AOR = 3.98, 95% CI: 1.68, 9.42].. Do you mean that there are no women with contracted pelvis who didn’t develop OL? Women with contracted pelvis will have 100% OL if it is not intervened timely. That is why I said the diagnosis of the contracted pelvis is overinflated. Could there be a diagnosis difficulty, the skill to diagnose?? � What about those far than 50 KMs? …. The odds of OL were 3.89 times more likely among women who reside within 10-50 kilometers estimated distance from the facility than those who reside below 10 kilometers distance [AOR= 3.89, 95% CI: 1.14, 13.3]. you may need to reclassify as >/=10KMs and do the analysis again. How was it possible to get the distance in KMs from the retrospective review? Discussion: This discussion in the first paragraph needs correction….A study conducted in LMICs [31] also showed that gravidity ≥ 2 was protective of OL. This variation might be due to socio-demographic differences and the lower risk of malpresentation and malposition among primigravida women… We rather expect more malpresentation and malposition in primigravida. The discussion part needs revision and the content must be seen carefully. Conclusion: Must be shortened and specific. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #3: No |
Formally Accepted |
PONE-D-21-03875R2 Determinants of obstructed labour and its adverse outcomes among women who gave birth in Hawassa University Referral Hospital: A case-control study Dear Dr. Desta: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Veneranda Masatu Bwana Guest Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .